WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60


Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here


Track Your Article



Dr. Swati Sharma M.D.*, Dr. Manoj Sharma M.S., Dr. C. P. Kashyap M.D., Dr. Vijayant Bhardwaj M.D., Ph.D.


The primary aim of Ayurveda is to cure the disease and to maintain health state. Medo Roga is a metabolic disorder which is very frequently encountered in routine clinical practice nowadays. In modern era with continuous changing life styles, faulty dietary habits and with some environmental factors man has become victim of many diseases including MedoRoga. MedoRoga is described in different classical texts. Acharya Charaka has described the disease in Ashtonindatiya Adhyaya. Acharya Charaka has explained the disease as Ati-sthoola under Niniditapurusha concept. Ati-sthool is a person in whom excessive and abnormal increase of Medodhatu along with Mansa dhatu, result in pendulous appearance of buttocks, abdomen and breast. This condition is presently described as obesity. This obesity presents itself as weight gain, increased B.M.I. and very commonly occurred altered lipid profile i.e. dyslipidemia. Medo Roga further leads to many disease conditions like Diabetes Mallitus, Hypertension etc. It is thus a serious public health problem. Metallic Bhasmas are highly valued in Ayurvedic treatment as they have good preventive, curative and rejuvenating potential due to its rapid dissolution, quick bioavailability, low dose requirement and easy palatability. Keeping in view this burning problem of present era and its associated devastating effects, the present research work has been chosen. Amritadya Guggulu has been advocated in sthaulya like condition and described as lekhana in our classical texts. Though nowadays it has been observed that dyslipidemia is also sometimes presents in non-obese subjects but considering common criteria in obese, this quantitative criterion has been selected. The proposed work was on 10 patients under open uncontrolled single group with Tamra Bhasma 60 mg as capsule & Amritadya Guggulu 500 mg in powder form (to be dispensed as capsule) with Luke warm water twice a day for 30 days. Follow up of the patients was on 15th day and after completion of the clinical trial.

Keywords: Medo Roga, Amritadya Guggulu, Dyslipidemia, Tamra Bhasma.

[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More